Replies to post #245705 on Biotech Values

[dewophile]

I hopped on this call about a half hour ago. The presenters were much more impressed with the GSK data and presentation
the vote on efficacy is happening now but the vote supporting approval is indeed a foregone conclusion and the the vote won't be as close as yesterday's 7-4
PS: Whether doctors in the community prefer GSK over PFE the way these committee members seem to only time will tell. I think a little under half get these vaccines from their MDs vs retail chains

EDIT vote was unanimous on efficacy.